# From stress to strength: mechanotransducing poly(aneu)ploidy into a community-level advantage in cancer

## TL;DR

This paper explores how cancer cells can adapt to poly(aneu)ploidy-induced stress and gain a survival advantage through biophysical and mechanobiological changes.

## Contribution

The paper provides new insights into how poly(aneu)ploidy can be mechanotransduced into adaptive advantages in cancer cell communities.

## Key findings

- Poly(aneu)ploid cancer cells can adaptively remodel their phenotype and resist damage.
- Biophysical adaptations include volume gain, membrane stretching, and altered endocytosis.
- Therapeutic strategies targeting poly(aneu)ploid cell vulnerabilities are emerging.

## Abstract

Poly(aneu)ploidy is a potent source of cellular stress that typically leads to loss of fitness, premature aging/senescence, and cell death. Yet in some systems, most notably microbial pathogens and human cancer cells under poly(aneu)ploidogenic stress, cells can adaptively remodel their phenotype, resist damage, and even convert this stress into a selective advantage. This mini-review examines current knowledge on the mechanisms underlying these adaptive responses in cancer cell communities and how poly(aneu)ploid subpopulations reshape the behavior of the entire population. Because poly(aneu)ploidy is almost invariably coupled to changes in cell size and morphology, we place particular emphasis on biophysical and mechanobiological adaptations. These include physico-chemical reprogramming, proteome remodeling, volume gain, membrane stretching, altered endocytosis, community-level metabolic rewiring, engagement of the nucleus as a key mechanosensor, and the role of mechanoreceptor channels. Finally, we discuss emerging therapeutic strategies that seek to exploit the specific vulnerabilities of poly(aneu)ploid cells. Together, these insights highlight the central role of poly(aneu)ploidy in enabling tumor adaptation and evolution, and point to new avenues for understanding cancer cell biology and designing future treatment strategies.